Artificial Intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: Early Value AssessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 20 May 2026
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke [TSID11920]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction [ID6514]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Extravascular implantable cardioverter defibrillator insertion for preventing sudden cardiac deathStatus:In development | In consultationProgramme:Interventional procedures guidanceConsultation end date: 10 April 2026Expected publication date: TBC